New York Life Investment Management LLC Sells 889 Shares of Encompass Health Co. (NYSE:EHC)

New York Life Investment Management LLC cut its stake in shares of Encompass Health Co. (NYSE:EHC) by 7.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,008 shares of the company’s stock after selling 889 shares during the quarter. New York Life Investment Management LLC’s holdings in Encompass Health were worth $1,017,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after buying an additional 137 shares in the last quarter. Avior Wealth Management LLC acquired a new position in shares of Encompass Health during the third quarter valued at about $40,000. Tompkins Financial Corp acquired a new position in shares of Encompass Health during the fourth quarter valued at about $46,000. V Square Quantitative Management LLC grew its holdings in shares of Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after buying an additional 177 shares during the last quarter. Finally, Morse Asset Management Inc acquired a new position in shares of Encompass Health during the third quarter valued at about $68,000. 97.25% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on EHC shares. Barclays lifted their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, February 7th. StockNews.com raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. KeyCorp raised their price target on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Monday, February 10th. Royal Bank of Canada reissued an “outperform” rating and set a $110.00 price target on shares of Encompass Health in a research report on Tuesday, February 11th. Finally, William Blair reissued an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $107.67.

Insider Activity

In other news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 2.10% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC stock opened at $99.73 on Tuesday. The firm has a market cap of $10.05 billion, a price-to-earnings ratio of 22.36, a P/E/G ratio of 2.31 and a beta of 0.90. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. Encompass Health Co. has a 52 week low of $74.27 and a 52 week high of $104.55. The firm’s 50-day simple moving average is $96.53 and its two-hundred day simple moving average is $96.50.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, equities analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 17th. Stockholders of record on Tuesday, April 1st will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.68%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is currently 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.